- Home
- VRDN vs IPAR Comparison
VRDN vs IPAR Comparison
Compare VRDN & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | IPAR |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | N/A | 1988 |
Fundamental Metrics
Financial Performance| Metric | VRDN | IPAR |
|---|---|---|
| Price | $31.17 | $85.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $40.45 | ★ $128.20 |
| AVG Volume (30 Days) | ★ 1.4M | 304.9K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 3.77% |
| EPS Growth | N/A | ★ 9.68 |
| EPS | N/A | ★ 5.13 |
| Revenue | $70,789,000.00 | ★ $1,463,838,000.00 |
| Revenue This Year | $26,257.62 | $3.42 |
| Revenue Next Year | $10.69 | $1.53 |
| P/E Ratio | ★ N/A | $16.55 |
| Revenue Growth | ★ 23340.07 | 3.12 |
| 52 Week Low | $9.90 | $77.21 |
| 52 Week High | $34.04 | $148.15 |
Technical Indicators
Market Signals| Indicator | VRDN | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 52.31 |
| Support Level | $30.57 | $84.16 |
| Resistance Level | $32.92 | $86.18 |
| Average True Range (ATR) | 0.98 | 1.99 |
| MACD | -0.39 | 0.46 |
| Stochastic Oscillator | 19.02 | 69.16 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About IPAR Inter Parfums Inc.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.